Cross-species validation of human specific STR system, SureID ® 21G and SureID ® 23comp (Health Gene Technologies) in Chimpanzee (Pan Troglodytes)
The human specific commercially available STRs system are often not tested in non human primates for their cross applicability. The aim of this study is to test Cross-species validation of two commercially available human specific STR kits i.e. SureID 21G and SureID 23comp (Health Gene Technologies)...
Saved in:
Published in | BMC research notes Vol. 12; no. 1; p. 750 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central
19.11.2019
BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The human specific commercially available STRs system are often not tested in non human primates for their cross applicability. The aim of this study is to test Cross-species validation of two commercially available human specific STR kits i.e. SureID
21G and SureID
23comp (Health Gene Technologies) for their positive application in Chimpanzee (Pan troglodytes).
In SureID
21G, 19 loci amplified and while 20 loci amplified in SureID
23comp. All the amplified loci in both STR kits were found polymorphic and the locus Amelogenin showed differential banding patterns between male and female revealing their known gender. The present study validates the applicability of these human specific STR kits in Chimpanzee that can be used in forensics analysis, paternity testing and population genetic studies. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
ISSN: | 1756-0500 1756-0500 |
DOI: | 10.1186/s13104-019-4801-3 |